BMRN vs MHK · P/E 40, rev $1.76B vs P/E 15, rev $5.72B
Biomarin Pharmaceutical Inc (BMRN) versus Mohawk Industries Inc (MHK) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Mohawk Industries Inc (MHK) is a furnishings, fixtures & appliances company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported MHK revenue for 2026-07-04 was $5.72B. Net income was $313.2M. MHK currently screens at market cap $7.12B and trailing P/E 14.9.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. MHK currently screens at market cap $7.12B and trailing P/E 14.9.
Not investment advice. Open the BMRN and MHK stock pages for the full models.
Not investment advice.